Cadus Price Prediction and Hype Density Breakdown

KDUS -- USA Stock  

USD 1.60  0.01  0.63%

Macroaxis is not in business of monitoring Cadus headlines and social sentiment data; there are plenty of companies out there that do it quite successfully. However, we do analyze noise-free headlines and recent hype associated with Cadus Corporation brand which may create opportunities for some arbitrage if properly timed. With Cadus hype-based prediction module you can estimate the value of Cadus Corporation from the prospective of Cadus response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Cadus over a specific investment horizon. Please see also Cadus Basic Forecasting Models to cross-verify your projections.
 Time Horizon     30 Days    Login   to change

Cadus After-Hype Price Density Analysis

 Next price density 
Expected price to next headline

Cadus Estimiated After-Hype Price Volatility

June 23, 2018
Current Value
After-hype Price
Target Odds
Cadus is risky asset. Analysis and calculation of next after-hype price of Cadus is based on 1 month time horizon.

Cadus Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.00% 0.73% 0.00%  0.00% 0 Events / Month7 Events / MonthUncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Cadus Hype Timeline

Cadus Corporation is now traded for1.60. This company stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Cadus Corporation is projected not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 0.0%. The immediate return on the next news is projected to be very small where as daily expected return is now at 0.0%. The volatility of relative hype elasticity to Cadus is about 63.81%%. The volatility of related hype on Cadus is about 63.81% with expected price after next announcement by competition of 1.6. About 69.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.12. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Cadus Corporation recorded loss per share of 0.12. This company had not issued any dividends in recent years. Given the investment horizon of 30 days, the next projected press release will be uncertain.
Please see also Cadus Basic Forecasting Models to cross-verify your projections.

Cadus Related Hype Analysis

At Risk
Regeneron Pharmaceuticals(1.84) 6 per month 0.61  0.37  3.01 (2.03)  5.97 
Alexion Pharmaceuticals(1.38) 4 per month 1.16  0.26  2.48 (1.71)  4.83 
Seattle Genetics 0.44 4 per month 0.81  0.41  3.70 (1.68)  10.30 
Sage Therapeutics(6.76) 3 per month 2.25  0.0054  1.85 (3.55)  23.17 
Loxo Oncology(0.20) 6 per month 1.16  0.24  3.12 (1.73)  8.35 
Blueprint Medicines Corporation(1.00) 5 per month 0.00 (0.22)  4.49 (7.29)  13.73 
Ascendis Pharma AS(1.77) 5 per month 1.76  0.0045  4.77 (3.08)  9.67 
Global Blood Therapeutics 1.40 5 per month 0.00 (0.12)  3.60 (3.95)  18.48 
Xencor(0.18) 3 per month 2.39  0.13  4.90 (1.83)  13.41 
Cambrex Corporation(0.15) 4 per month 0.00 (0.0325)  1.56 (2.00)  3.40 

Contributor Headline

Latest Prospective on Cadus
Investors are also interested in
Purchased over 100 shares
Active over a week ago
Please see also Cadus Basic Forecasting Models to cross-verify your projections. Please also try Headlines Timeline module to stay connected to all market stories and filter out noise. drill down to analyze hype elasticity.